Key Record Dates
| ClinicalTrials.gov Identifier: | NCT04164901 |
|---|---|
| Brief Title: | Study of Vorasidenib (AG-881) in Participants With Residual or Recurrent Grade 2 Glioma With an IDH1 or IDH2 Mutation (INDIGO) |
| First Submitted : | November 11, 2019 |
| First Submitted that Met QC Criteria : | November 14, 2019 |
| First Posted : | November 15, 2019 |
| Last Update Submitted that Met QC Criteria : | May 16, 2022 |
| Last Update Posted : | May 17, 2022 |